Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procrit in elderly patients with anemia of chronic disease
NCT00210795Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Jun 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 2 trial of epoetin alfa in anemia of chronic disease (ACD), sponsored by Johnson & Johnson. Started Jun 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT00210795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210795.